Skip to content
OpenCapital
Get started

Allogene Therapeutics ALLO Enterprise value

Enterprise value at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$158.92B-2.6%
Gilead Sciences logo
Gilead SciencesGILD
$187.53B+19.7%
Precigen logo
PrecigenPGEN
$1.46B+234%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
$4.93B+69.8%
Sana Biotechnology logo
Sana BiotechnologySANA
$760.1M+104%
CytomX Therapeutics logo
CytomX TherapeuticsCTMX
$990.06M+8,530%

Other financials

Income statement

See full
Revenue-—
Operating income-$46.1M+29.3%
Net income-$42.6M+28.7%
EPS (diluted)-$0.18+35.7%

Balance sheet

See full
Cash & equivalents$40.6M-23.0%
Total debt$81.1M-8.9%
Total equity$278.9M-27.6%
Total assets$396.0M-22.1%

Cash flow

See full
Operating cash flow-$12.9M+75.6%
CapEx$9.0K-90.9%
Free cash flow-$12.9M+75.6%

Valuation

See full
Market cap$711.02M+164%

Profitability

See full
Operating margin-1,241,813.6%-2,018,140pp
Net margin-1,170,863.6%-2,007,890pp
FCF margin-913,609.1%-1,474,890pp

Returns & leverage

See full
Return on equity-52.3%-5.7pp
Debt / equity0.3×+0.1×
Current ratio9.6×-0.1×

Where this comes from

Calculated from Allogene Therapeutics’s reported figures.

$594.8Mmarket cap+$81.1Mtotal debt−$40.6Mcash and equivalents=$635.27M

The official record: Allogene Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Allogene Therapeutics's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Allogene Therapeutics's enterprise value?
Allogene Therapeutics (ALLO) reported enterprise value of $635.27M in Q1 2026.
How has Allogene Therapeutics's enterprise value changed year-over-year?
Allogene Therapeutics's enterprise value increased by 79.8% year-over-year, from $353.38M to $635.27M.
What is the long-term trend for Allogene Therapeutics's enterprise value?
Over 5 years (2020 to 2025), Allogene Therapeutics's enterprise value has grown at a -37.5% compound annual growth rate (CAGR), from $3.46B to $329.15M.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.